评价具有CD20-或CD20+特征的t(11;14)骨髓瘤患者临床疗效差异性
赵卫红, 黄彬涛, 刘瑞, 向彩霞
Evaluating the difference in clinical efficacy for t(11;14) multiple myeloma patients with CD20- or CD20+
ZHAO Weihong, HUANG Bintao, LIU Rui, XIANG Caixia
基础医学与临床
.
2023, (9): 1423
-1427
.
DOI: 10.16352/j.issn.1001-6325.2023.09.1423
